Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

15drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Fruquintinib ×

Fruquintinib

This drug is selected. Its supporting articles are shown below.

Fruquintinib3

Articles mentioning Fruquintinib

3 articles · page 1 of 1

Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging

bmjonc · full text · 2026-04-07 · 5 matching annotations

97.8%

Zykadia Cyramza Fruzaqla Fruquintinib Imfinzi durvalumab ramucirumab Brigatinib ceritinib

…), atezolizumab (Tecentriq), osimertinib (Tagrisso), ceritinib (Zykadia) and nintedanib (Vargatef). EMA labels for all products include…

4CPS-308 Analysis of the effectiveness and safety of fruquintinib in metastatic colorectal cancer in real-world clinical practice

ejhpharm · abstract · 2026-03-18 · 5 matching annotations

99.4%

fruquintinib regorafenib TAS-102 trifluridine-tipiracil bevacizumab mCRC metastatic colorectal cancer (mCRC)tertiary hospitals

…. The median number of prior treatment lines was four. Prior to fruquintinib, 22 patients had received TAS-102 plus bevacizumab, eight recei…

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol

bmjopen · abstract · 2025-09-26 · 5 matching annotations

98.9%

Fruquintinib sintilimab CAPEOX oxaliplatin capecitabine chemotherapy immunotherapy

…cer, although there remains a need for improvement in efficacy. Fruquintinib, an oral and highly selective vascular endothelial growth facto…